Study of the correlation between doses and blood concentration of Liposomal-Amphotericin B (L-AMB) in children

Study of the correlation between doses and blood concentration of Liposomal-Amphotericin B (L-AMB) in children - Study of the correlation between doses and blood concentration of Liposomal-Amphotericin B (L-AMB) in children

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015176

Enrollment

Registered

2014-09-16

Start date

2012-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

febrile neutropenia or cryptosporidiosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: An inpatient with febrile neutropenia or cryptosporidiosis who need the Liposomal-Amphotericin B therapy. The patients who gave a concent to participate in this study.

Exclusion criteria

Exclusion criteria: The patients who has an allergy of the Liposomal-Amphotericin B. The patients who is administrating of other intravenous antifungal drugs. The patients who is judged inadequate for this study by the doctor.

Design outcomes

Primary

Measure	Time frame
The association between administration dose of Liposomal-Amphotericin B and plasma concentration The association between trough plasma concentration of Liposomal-Amphotericin B and renala function	—

Secondary

Measure	Time frame
The associaetion between trough plasma concentration of Liposomal-Amphotericin B and outcome	—

Countries

Japan

Contacts

Public ContactNARITA Atsushi

Nagoya University Graduate School of Medicine Department of Pediatrics

stanza-la-speranza@nifty.com052-744-2294

Outcome results